Mark W Fear Selected Research

Length of Stay

11/2020	Retrospective cohort study of health service use for cardiovascular disease among adults with and without a record of injury hospital admission.
9/2017	Identification of factors predicting scar outcome after burn in adults: A prospective case-control study.
5/2017	Burn leads to long-term elevated admissions to hospital for gastrointestinal disease in a West Australian population based study.
3/2017	Burns and long-term infectious disease morbidity: A population-based study.
12/2016	Increased admissions for diabetes mellitus after burn.
3/2016	Understanding the long-term impacts of burn on the cardiovascular system.
1/2016	Burn injury and long-term nervous system morbidity: a population-based cohort study.
12/2015	Increased admissions for musculoskeletal diseases after burns sustained during childhood and adolescence.
11/2015	Long-term Effects of Pediatric Burns on the Circulatory System.
9/2015	Long-term musculoskeletal morbidity after adult burn injury: a population-based cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark W Fear Research Topics

Disease

37	Burns 03/2024 - 01/2008
17	Wounds and Injuries (Trauma) 10/2020 - 09/2007
15	Cicatrix (Scar) 01/2023 - 05/2009
7	Keloid 01/2022 - 08/2016
3	Fibrosis (Cirrhosis) 01/2023 - 04/2020
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 01/2020
2	Pain (Aches) 01/2018 - 09/2015
2	Communicable Diseases (Infectious Diseases) 01/2018 - 03/2017
2	Neurogenic Inflammation 01/2018 - 09/2015
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2017 - 03/2017
2	Bacterial Pneumonia 01/2017 - 10/2016
2	Human Influenza (Influenza) 01/2017 - 10/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017 - 10/2016
2	Viral Pneumonia 01/2017 - 10/2016
2	Nervous System Diseases (Neurological Disorders) 01/2016 - 01/2010
2	Musculoskeletal Diseases (Musculoskeletal Disease) 12/2015 - 09/2015
1	Blister (Bulla) 03/2024
1	Thrombosis (Thrombus) 10/2023
1	Vascular System Injuries 10/2023
1	Hemolysis 01/2023
1	Inflammation (Inflammations) 01/2023
1	Infections 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Surgical Wound 10/2020
1	Surgical Wound Infection 10/2020
1	Obesity 04/2020
1	Diphtheria 01/2020
1	Tetanus 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Eosinophilia 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Diabetes Mellitus 12/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2016
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2016
1	Heart Diseases (Heart Disease) 03/2016
1	Heart Failure 03/2016

Drug/Important Bio-Agent (IBA)

14	insulin receptor-related receptor (IRR)IBA 01/2019 - 09/2015
8	CollagenIBA 10/2023 - 05/2009
6	CytokinesIBA 01/2023 - 08/2015
5	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2008
2	Peptides (Polypeptides)IBA 10/2023 - 01/2008
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2022
2	Phosphatidylethanolamines (Cephalins)IBA 01/2023 - 01/2023
2	LipidsIBA 01/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2020
2	VaccinesIBA 01/2020 - 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2024
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2024
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	lysophosphatidylethanolamineIBA 01/2023
1	AcidsIBA 01/2023
1	Amino Acids FDA Link 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023
1	VLDL LipoproteinsIBA 01/2023
1	Biogenic Amines (Biogenic Amine)IBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Quinolinic AcidIBA 01/2022
1	EnzymesIBA 01/2022
1	blebbistatinIBA 10/2021
1	Histones (Histone)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	CytosineIBA 06/2020
1	DNA (Deoxyribonucleic Acid)IBA 06/2020
1	Interleukin-6 (Interleukin 6)IBA 04/2020
1	Pertussis VaccineIBA 01/2020
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	Extracellular Matrix ProteinsIBA 01/2020
1	AntigensIBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	Ephrin-A2 (Ephrin A2)IBA 01/2019
1	LigandsIBA 01/2019
1	EphrinsIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 11/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	AllergensIBA 01/2018
1	SmokeIBA 01/2017
1	Insulin (Novolin)FDA Link 12/2016
1	Blood Glucose (Blood Sugar)IBA 12/2016
1	Verapamil (Calan)FDA LinkGeneric 08/2016
1	Triamcinolone (Aristocort)FDA Link 08/2016
1	Hormones (Hormone)IBA 11/2015
1	CatecholaminesIBA 11/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2015
1	zinc thioneinIBA 05/2012
1	Substance PIBA 11/2011
1	Pyruvic Acid (Pyruvate)IBA 03/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2010
1	Thiamine (Aneurin)FDA Link 03/2010

Therapy/Procedure

10	Length of Stay 11/2020 - 09/2015
2	Therapeutics 01/2024 - 05/2012
2	Gas Lasers 01/2023 - 06/2019
2	Lasers (Laser) 01/2023 - 06/2019
2	Operative Surgical Procedures 01/2019 - 01/2017
1	Transcranial Magnetic Stimulation 01/2024
1	Debridement 11/2022
1	Cesarean Section (Caesarean Section) 10/2020
1	Negative-Pressure Wound Therapy 10/2020
1	Intralesional Injections 08/2016
1	Skin Transplantation (Skin Grafting) 06/2013